- English (USA)
- English (UK)
- English (India)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Abivax SA (ABVX)
Abivax SA stock price live, this page displays EPA ABVX stock exchange data. View the ABVX premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Abivax SA real time stock price chart below.
What Is the Abivax SA Stock Price Today?
The Abivax SA stock price today is 106.60.
What Is the Stock Symbol for Abivax SA?
The stock symbol for Abivax SA is "ABVX."
What Stock Exchange Does Abivax SA Trade On?
Abivax SA is listed and trades on the Paris stock exchange.
Is Abivax SA a Good Stock to Buy?
Determining whether Abivax SA—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the ABVX quote. (ISIN: FR0012333284)
What Is the Abivax SA Stock Price Today?
The Abivax SA stock price today is 106.60.
What Is the Stock Symbol for Abivax SA?
The stock symbol for Abivax SA is "ABVX."
What Stock Exchange Does Abivax SA Trade On?
Abivax SA is listed and trades on the Paris stock exchange.
Is Abivax SA a Good Stock to Buy?
Determining whether Abivax SA—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the ABVX quote. (ISIN: FR0012333284)
106.60
+2.60(+2.50%)
Closed·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
103.20
107.20
52 wk Range
4.51
132.00
ABVX is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
103.20107.20
52 wk Range
4.51132.00
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockABVX Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Price Target
109.03
Upside
+2.28%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Stock price often moves in the opposite direction of the market
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy
Abivax SA Company Profile
ABIVAX Société Anonyme, a clinical-stage biotechnology company, focuses on developing therapeutics that harness the body’s natural regulatory mechanisms to stabilize the immune response in patients with chronic inflammatory diseases. Its lead drug candidate includes obefazimod that is in Phase 3 clinical trials for the treatment of adults with moderately to severely active ulcerative colitis, as well as in Phase 2b clinical trial to treat patients with Crohn’s disease. The company was incorporated in 2013 and is headquartered in Paris, France.
Compare ABVX to Peers and Sector
Metrics to compare | ABVX | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipABVXPeersSector | |
|---|---|---|---|---|
P/E Ratio | −28.3x | −3.4x | −0.6x | |
PEG Ratio | 0.63 | 0.02 | 0.00 | |
Price/Book | 16.2x | 0.7x | 2.6x | |
Price / LTM Sales | 1,562.2x | 16.0x | 3.4x | |
Upside (Analyst Target) | 14.6% | 138.3% | 41.8% | |
Fair Value Upside | Unlock | 0.9% | 4.8% | Unlock |
Analyst Ratings
5 Buy
1 Hold
0 Sell
Ratings:
6 analysts
Overall Consensus
Buy
Analysts 12-Month Price Target:
Average 109.03
(+2.28% Upside)
Earnings
Latest Release
Dec 15, 2025
EPS / Forecast
-2.10 / -0.625
Revenue / Forecast
2.04M / 1.26M
People Also Watch
FAQ
What Is the Abivax SA (ABVX) Stock Price Today?
The Abivax SA stock price today is 106.60
What Stock Exchange Does Abivax SA Trade On?
Abivax SA is listed and trades on the Paris Stock Exchange stock exchange.
What Is the Stock Symbol for Abivax SA?
The stock symbol for Abivax SA is "ABVX."
What Is the Abivax SA Market Cap?
As of today, Abivax SA market cap is 8.30B.
What Is Abivax SA's Earnings Per Share (TTM)?
The Abivax SA EPS (TTM) is -4.46.
When Is the Next Abivax SA Earnings Date?
Abivax SA will release its next earnings report on Mar 23, 2026.
From a Technical Analysis Perspective, Is ABVX a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
How Many Times Has Abivax SA Stock Split?
Abivax SA has split 0 times.
How Many Employees Does Abivax SA Have?
Abivax SA has 67 employees.
What is the current trading status of Abivax SA (ABVX)?
As of Jan 26, 2026, Abivax SA (ABVX) is trading at a price of 106.60, with a previous close of 106.60. The stock has fluctuated within a day range of 103.20 to 107.20, while its 52-week range spans from 4.51 to 132.00.
What Is Abivax SA (ABVX) Price Target According to Analysts?
The average 12-month price target for Abivax SA is EUR109.03, with a high estimate of EUR142 and a low estimate of EUR63. 5 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Buy. The stock has an +2.28% Upside potential.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.